Anupam Rasayan India Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anupam Rasayan India Ltd is ₹ 1242 as of 23 Mar 15:30 . The P/E Ratio of Anupam Rasayan India Ltd changed from 69.7 on March 2021 to 89.8 on March 2025 . This represents a CAGR of 5.20% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Anupam Rasayan India Ltd changed from ₹ 4900 crore on March 2021 to ₹ 8382 crore on March 2025 . This represents a CAGR of 11.33% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Anupam Rasayan India Ltd for the Dec '25 is ₹ 514.55 crore as compare to the Sep '25 revenue of ₹ 739.19 crore. This represent the decline of -30.39% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anupam Rasayan India Ltd for the Dec '25 is ₹ 129.58 crore as compare to the Sep '25 ebitda of ₹ 143.58 crore. This represent the decline of -9.75% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anupam Rasayan India Ltd changed from ₹ 12.21 crore to ₹ 60.59 crore over 7 quarters. This represents a CAGR of 149.77% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Anupam Rasayan India Ltd changed from 7.15 % on March 2021 to 11.35 % on March 2025 . This represents a CAGR of 9.68% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anupam Rasayan India Ltd

Anupam Rasayan India Limited was initially formed as a Partnership Firm as 'Anupam Rasayan' effective from April 01, 1984 at Surat in Gujarat.
The Partnership Firm was registered under the Indian Partnership Act, 1932 with Registrar of Firms, Surat in October 22, 1984. Subsequently, the Partnership Firm converted into a joint stock company and was registered as a Public Limited Company under the name 'Anupam Rasayan India Limited' dated September 30, 2003, issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company received Certificate of Commencement of Business, issued by Assistant Registrar of Companies, Gujarat, on November 20, 2003. The Company is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Anupam Rasayan India Ltd or Saroja Pharma Industries India Ltd?

Market cap of Anupam Rasayan India Ltd is 14,253 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Anupam Rasayan India Ltd stock price is INR ₹1251.95. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Anupam Rasayan India Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.